Related by context. All words. (Click for frequent words.) 75 Therapeutic Vaccines 74 Protein Kinase Inhibitors 74 Inflammatory Disease 74 Autoimmune Disease 73 Inflammatory Arthritis 73 Lung Cancer Drug 73 Mimetics 73 Clinical Outcome 73 Analytical Tool 73 Targeted Therapies 73 Monoclonal Antibodies 73 Drug Shows Promise 73 Cancer Stem Cells 73 Immunotherapeutic 73 Anti Tumor 73 Therapeutic Antibody 72 Aurora Kinase 72 Smooth Muscle 72 Prostate Cancer Vaccine 72 Small Molecule 72 Prolongs Survival 72 Protein Interactions 72 Antiangiogenic 72 Systemic Delivery 72 Lupus Drug 72 Hematological Cancers 72 Rotavirus Vaccine 71 Therapeutic Targets 71 Monoclonal Antibody 71 Hepatocellular Carcinoma 71 Gastric Cancer 71 Rheumatoid Arthritis Drug 71 RNAi Therapeutics 71 Novel Therapeutic 71 Dendritic Cells 71 Autoimmune Disorders 71 Gout Drug 71 Therapeutic Antibodies 71 RNA Interference 71 Novel Therapies 71 Drug Candidate 71 Gene Silencing 71 Inflammatory Diseases 71 Therapeutic Vaccine 71 Genes Involved 71 Myelodysplastic Syndromes 71 Vaccine Adjuvant 71 Breast Tumors 70 Antiviral Drugs 70 Malaria Vaccine 70 Phase 2b Clinical Trial 70 Protein Synthesis 70 Immune Responses 70 Therapeutic Potential 70 Advanced Melanoma 70 Chemoprevention 70 Present Preclinical Data 70 Clinical Trial Results 70 Estrogen Receptor 70 Inflammatory Markers 70 Emerging Therapies 70 Drug Pipeline 70 Vaccine Protects Against 70 Atopic Dermatitis 70 Initiates Clinical 70 Genetic Variation 70 Blood Pressure Drug 70 Subtypes 70 Tyrosine Kinase Inhibitor 70 Clinical Trial Data 70 Vaccine Candidate 70 Aptamer 70 Preclinical Models 70 Renal Cell Carcinoma 69 Vitro Activity 69 Respiratory Virus 69 Stakeholder Opinions 69 Test Detects 69 Shows Promise Against 69 Novel Antibiotic 69 Small Molecules 69 Avian Flu Vaccine 69 Cancer Therapies 69 Human Monoclonal Antibodies 69 Recombinant Human 69 Phase 1b Clinical Trial 69 Antisense Drug 69 Protein Involved 69 Shows Promising 69 Breast Cancer Metastasis 69 TB Vaccine 69 Topical Treatment 69 Asthma COPD 69 Cholesterol Lowering Drug 69 Seasonal Influenza Vaccine 69 Antitumor 69 Viral Infections 69 Kinase Inhibitor 69 Multidrug Resistant 69 Anticancer Agent 69 Combination Therapy 69 Biosimilar 69 Protein Linked 69 Nicotine Vaccine 69 HDAC Inhibitor 69 Lung Cancer Survival 69 Erectile Dysfunction Drug 69 Improves Survival 69 Statin Drugs 69 Anticancer Drug 69 Pooled Analysis 69 Mouse Models 69 Phase IIb Clinical Trial 69 Lung Cancer Trial 69 HCV Protease Inhibitor 69 Hepatitis C Virus 69 Tumor Suppressor 69 Antitumor Activity 69 Gene Mutation 69 Protein Therapeutics 69 Oligonucleotides 69 Signaling Pathway 69 Anticancer Drugs 69 Drug Resistant 69 RNAi Therapeutic 69 Epilepsy Drug 69 Drug Fails 69 Antifungals 69 Dose Escalation 69 Tumor Targeting 69 Universal Flu Vaccine 69 Protein Biomarker 68 Dengue Virus 68 Personalised Medicine 68 Early Diagnosis 68 Novel Inhibitor 68 Immune Cells 68 Metabolic Disease 68 Breast Cancer Recurrence 68 Gastrointestinal Disorders 68 Antiviral Activity 68 Phase 2a Trial 68 Osteoporosis Treatment 68 Protein Expression 68 Lymphoid 68 Diagnostic Tests 68 Molecular Diagnostic 68 Successfully Completes Phase 68 Synthetic Peptide 68 Autoimmune Diseases 68 Hormonal Therapy 68 Treating Chronic 68 Therapeutic Efficacy 68 Experimental Vaccine 68 Prognostic Value 68 Phase 2b Trial 68 Smallpox Vaccine 68 Targeted Therapy 68 Novel Mechanism 68 Phase III Trials 68 Completes Patient Enrollment 68 Shows Efficacy 68 Chronic Lymphocytic Leukemia 68 Adjuvant Chemotherapy 68 Immunotherapies 68 Genes Linked 68 Shown Effective 68 Fungal Infections 68 Patient Enrollment 68 Gastrointestinal Stromal Tumors 68 Hormone Refractory Prostate Cancer 68 Gene Linked 68 Circulating Tumor Cells 68 Metabolic Disorder 68 Antibody Discovery 68 Migraine Drug 68 Antibody Drug Conjugate 68 Phase 2a Clinical Trial 68 Placebo Controlled Trial 68 Preclinical Data 68 Anti Inflammatory Drug 68 Rheumatoid Arthritis Patients 68 Novel Treatments 68 Submits NDA 68 FDA Approvals 68 Universal Influenza Vaccine 68 Investigational Compound 68 Antisense 68 Cancer Biomarkers 68 Nanoemulsion 68 Novel Protein 68 Oral Mucositis 68 Diagnosis Treatment 68 Initiate Clinical Trial 68 JAK Inhibitor 68 Regimens 68 Neural Stem Cells 68 Antigen Specific 68 Pharmacogenomic 68 Epidermal Growth Factor Receptor 68 TNF Alpha 68 Benign Prostatic Hyperplasia 68 Blood Clotting 67 Anti Inflammatory 67 Retrovirus 67 BiTE Antibody 67 Transdermal Delivery 67 Osteoporosis Drug 67 Chronic Myeloid Leukemia 67 Male Contraceptive 67 Kinase Inhibitors 67 Human Antibody 67 Anti Angiogenesis 67 Ebola Vaccine 67 Lung Cancer Treatment 67 Appears Safe 67 Vaccine Shows Promise 67 Chemokine Receptor 67 Signaling Pathways 67 Preclinical Study 67 Chemotherapeutic Agents 67 Disease Progression 67 Brain Tumors 67 Drug Prevents 67 Genes Identified 67 Treatment Shows Promise 67 Drug Combo 67 Collaborators Publish 67 Virus Infection 67 Tezampanel 67 Hsp# Inhibitor 67 Stomach Cancer 67 Commonly Used 67 Breast Cancer Cells 67 Pre Cancerous 67 Receives Milestone Payment 67 Initiates Clinical Trial 67 Bazedoxifene 67 Susceptibility Gene 67 Angiogenic 67 Pipeline Analysis 67 Factor Receptor 67 See CLINICAL PHARMACOLOGY 67 Neuroprotection 67 Cardiotoxicity 67 Receives Orphan Drug Designation 67 Previously Treated 67 NDA Submission 67 Hematological Malignancies 67 Slow Progression 67 Genetic Variations 67 Treatment Reduces 67 HIV Integrase 67 Presents Preclinical Data 67 Mouse Model 67 Investigational Treatment 67 Hematological 67 Vascular Targeting Agents 67 Receives Orphan Drug 67 Investigational Agent 67 Tumor Cells 67 Vaccine Adjuvants 67 Renal Cancer 67 Effective Treatments 67 Immunomodulatory 67 Prognostic Factors 67 Hepatitis C Infection 67 Ovarian Cancers 67 Leukemias 67 Cognitive Deficits 67 Imaging Technique 67 Skeletal Muscle 67 Interferon Gamma 67 Novel Approaches 67 Antifungal 67 Brain Wiring 67 Novel Vaccine 67 Meets Primary Endpoint 67 Nerve Regeneration 67 Survival Benefit 67 Peripheral Blood 67 Cannabinoid 67 Novel Oral 67 Contrast Agents 67 Immunostimulatory 67 Metastatic Melanoma 67 Anti Tumor Activity 67 Molecular Diagnostic Test 67 Protease Inhibitor 67 Genetic Mutation 67 Polymerase Inhibitor 67 Brain Metastases 67 FDA Okays 67 Minimally Invasive Treatment 67 First Patient Dosed 67 Arthritis Drug 67 Preclinical Studies 67 Protein Kinase 66 Anti Infectives 66 Imaging Techniques 66 Immunomedics Announces 66 Neoadjuvant Chemotherapy 66 Soy Isoflavones 66 Valopicitabine 66 Newly Identified 66 Biocompatibility 66 Differential Diagnosis 66 Elagolix 66 Microfluidic Devices 66 Molecular Basis 66 Demonstrates Potent 66 Immunologic 66 Allergic Rhinitis 66 Cancer Immunotherapy 66 Non Invasive Treatment 66 IND Filing 66 Long Term Survival 66 Cancer Vaccine 66 Septic Shock 66 Aggressive Prostate Cancer 66 Therapeutic Protein 66 Innate Immune 66 Diabetic Foot Ulcer 66 Demonstrates Efficacy 66 Clinically Tested 66 Hypercholesterolemia 66 Cancer Treatments 66 Asthma Treatment 66 Postdoctoral Position 66 Pivotal Trials 66 Antibody Therapeutics 66 Influenza Virus 66 Mesothelioma Treatment 66 DNA Methylation 66 Investigational Drug 66 Estrogen Therapy 66 Therapy Improves 66 Insulin Resistance 66 Pandemic Flu Vaccine 66 Combination REOLYSIN R 66 Therapeutic Monoclonal Antibodies 66 Chronic Inflammation 66 Multiple Myeloma Patients 66 Kidney Transplant Patients 66 Biomarker Study 66 Adjuvanted 66 Cervical Dysplasia 66 Cardiovascular Disease Risk 66 Phase 2b Study 66 Randomized Clinical Trials 66 Sleep Disturbances 66 Molecular Mechanism 66 Malignant Melanoma 66 Allogeneic 66 Liver Toxicity 66 Pandemic Influenza Vaccine 66 Hematopoietic 66 Nucleic Acid 66 Interferon Beta 66 Pharmacokinetic Study 66 Cell Transplants 66 FDA Approves Drug 66 Schizophrenia Treatment 66 Biologic Drugs 66 Innate Immunity 66 Personalized Immunotherapy 66 Psoriasis Drug 66 Study Evaluating 66 Histone Deacetylase 66 Orphan Diseases 66 Companion Diagnostic 66 Serious Infections 66 Epithelial Cell 66 Metastatic Cancer 66 Demonstrates Significant 66 Demonstrates Statistically Significant 66 Files IND 66 Patients Suffering 66 Anthracycline 66 Bladder Cancer 66 Bone Metastases 66 Conjugated 66 Progenitor Cells 66 Ovarian Cancer Patients 66 Lowers Risk 66 Ovarian Cancer Treatment 66 Stem Cell Transplants 66 Predict Breast Cancer 66 Cell Adhesion 66 Treatment Algorithm 66 Unresectable 66 Allosteric 66 Immune Mediated 66 Prolongs Life 66 Antibacterials 66 Gene Variant 66 Somatostatin 66 Sustained Release 66 Phase III Clinical Trials 66 ARRY # 66 Immunogenicity 66 Adjuvant Treatment 66 Angiogenesis 66 Exelixis XL# 66 Ridaforolimus 66 Pralatrexate 66 Vicriviroc 66 Renal Cell Cancer 66 Gene Variants 66 Endothelial Cells 66 Nucleoside 66 Oligonucleotide 66 Randomized Phase II 66 Antiviral Drug 66 IND Application 65 Scientists Identify 65 Statistically Significant 65 Preclinical Development 65 Oral Fingolimod 65 Treatment Regimen 65 Taxane 65 Gene Mutations 65 Diabetic Neuropathy 65 Acute Heart Failure 65 Receptor Agonist 65 Trial Evaluating 65 Lupus Nephritis 65 Combination Treatment 65 Blood Vessels 65 Genetic Predisposition 65 Antithrombotic 65 Genetic Tests 65 Lowering Blood Pressure 65 Demonstrates Potential 65 Novel Compounds 65 Immune Cell 65 Pandemic Influenza Vaccines 65 Refractory Angina 65 Seasonal Influenza 65 Enlarged Prostate 65 Tumor Suppressor Gene 65 Oral Presentations 65 Improves Outcomes 65 Sapacitabine 65 Single Dose 65 Antipsychotic Drug 65 Overactive Bladder 65 Milestone Payment 65 Breast Cancer Treatment 65 Nymox NX 65 Antiviral 65 DNA Sequencing 65 Cytotoxic 65 Effectively Treats 65 Extracellular Matrix 65 Influenza Vaccine 65 Clinical Proteomics 65 Venous Thromboembolism 65 Showed Significant 65 Epitopes 65 Replacement Therapy 65 Combo Therapy 65 Diagnostic Criteria 65 Potent Anti 65 Technological Advances 65 Oral Cavity 65 Advanced Renal Cell 65 Anticancer Agents 65 Diamyd Medical Diamyd 65 Low Dose 65 Treating Depression 65 Stem Cell Treatments 65 Transdermal Patch 65 Mucosal 65 Genetic Marker 65 Hepatitis C Treatment 65 Medullary Thyroid Cancer 65 Neurodegenerative 65 Tumor Microenvironment 65 Mutational 65 Develop Novel 65 Retroviral 65 Inhaled Corticosteroids 65 Colorectal Screening 65 Hepatitis C Virus HCV 65 Beneficial Effects 65 Transcription Factor 65 Transcriptome 65 Diabetic Nephropathy 65 Mammalian Cell Culture 65 Aliskiren 65 Gene Expression Profiling 65 Predict Prostate Cancer 65 Antigens 65 Parathyroid Hormone 65 FDA Accepts 65 Radioimmunotherapy 65 Protease Inhibitors 65 Pertuzumab 65 Initiates Phase III 65 Signal Transduction 65 Lung Cancer Patients 65 HER2 Positive 65 Schizophrenia Drug 65 Small Molecule Inhibitors 65 Pre Exposure Prophylaxis 65 rxRNA 65 Presents Positive 65 Disease Causing 65 Randomized Controlled Trials 65 HCV Infection 65 Improve Survival 65 Heartburn Drugs 65 Migraine Treatment 65 Tumor Growth 65 Risk Stratification 65 Antibiotic Resistant 65 Stem Cell Treatment 65 Factor VIIa 65 Data Suggest 65 Cholesterol Drug 65 Gene Variation 65 Nucleic Acids 65 Advanced Colorectal Cancer 65 Intravenous Formulation 65 Novel Therapeutics 65 Glufosfamide 65 Hepatitis B Vaccine 65 Nerve Cell 65 Chemotherapeutic 65 Genetic Testing 65 Tumor Targeted 65 Ultrasensitive 65 Proteasome 65 Unfractionated Heparin 65 Prostate Cancer Patients 65 Thyroid Hormone 65 Achieves Primary Endpoint 65 Magnetic Nanoparticles 65 Toxicogenomics 65 Dasatinib 65 Drug Regimen 65 Anticancer Activity 65 Oncogene 65 Gamma secretase 65 Liposomal 65 JAK2 Inhibitor 65 Kidney Function 65 Oral Insulin 65 Tumor Response 65 Phase IIb Trial 65 Protein Structure 65 Clinical Trial Enrollment 65 Prostate Cancer Treatment 65 Protease 65 Endovascular Treatment 65 ASCO GI 65 Islet Transplantation 65 Immunosuppressant 65 Cancer Cells 65 Protein Interaction 65 Sangamo BioSciences Announces 65 Therapy Shows Promise 65 Therapeutic Effects 65 Maribavir 65 Anti Nausea 64 Hormone Receptor Positive 64 Fibroblast 64 Companion Diagnostics 64 Hormone Replacement 64 Phase III Clinical Trial 64 Disease Modifying 64 Biopharmaceutical Industry 64 Phase Ib Clinical Trial 64 Genes Predict 64 Chronic Sinusitis 64 Treated Patients 64 Protein Microarrays 64 Tumor Markers 64 Artificial Pancreas 64 Neurodegenerative Disease 64 Adjuvant Therapy 64 Anti CD# Antibody 64 Long Term Efficacy 64 Growth Hormone Deficiency 64 Vaccine Trial 64 First Patient Enrolled 64 Orally Active 64 Fat Cells 64 Interferon Alpha 64 Adenoma 64 Protein Biomarkers 64 Tuberculosis Vaccine 64 Completes Dosing 64 Activity Assay 64 Systemic Sclerosis 64 Archexin 64 Reduced Risk 64 Prostate Tumors 64 Fabry Disease 64 Preclinical Evaluation 64 Microbicide 64 Potent Inhibitor 64 Clinical Efficacy 64 Severe Sepsis 64 Therapy Evaluation 64 Trodusquemine MSI 64 Recombinant Protein 64 PDE# 64 Beta Blocker 64 platform HDL Mimetic 64 Patients Treated With 64 XYOTAX TM 64 Treatment Naive Patients 64 siRNA Delivery 64 Antibiotic Resistance 64 Gene Therapy Trial 64 Hernia Repair 64 Stapled Peptide 64 Cutaneous T 64 Fast Track Status 64 SCIB1 64 Therapeutic Areas 64 Adenoviral 64 Human Monoclonal Antibody 64 Molecular Cancer 64 KL4 Surfactant 64 Urinary Incontinence 64 Immunotherapy 64 Sipuleucel T 64 Confirms Efficacy 64 Deforolimus 64 Skin Cancers 64 Detect Cancer 64 Biosimilars 64 Anemia Drug 64 Therapy Reduces 64 Oxidative Stress 64 Lentiviral 64 Hormone Therapy 64 Dehydrogenase 64 Receptor Antagonist 64 Biologic Therapy 64 Cytotoxicity 64 Immunosuppressive 64 Treatment Naïve 64 Adult Stem Cell Therapy 64 Shows Statistically Significant 64 Preterm Delivery 64 Influenza Vaccine Production 64 Ichor Medical Systems 64 Tablet Formulation 64 Solid Tumor 64 Demonstrated Significant 64 Biological Therapy 64 Premature Aging 64 Chemotherapy Regimen 64 Malaria Parasite 64 tubulin inhibitor 64 Fibrinogen 64 Subtype 64 Vitro Diagnostic 64 Malignant Glioma 64 Osteoarthritis Pain 64 Endometrial Cancer 64 Electroporation 64 Metabolic Endocrinology 64 Clostridium difficile Infection 64 Bone Marrow Cells 64 Myeloma Patients 64 Drug Resistant Bacteria 64 Prostate Cancer Survival 64 Osteoporosis Drugs 64 DNA Microarray 64 Cholinesterase Inhibitors 64 Novel Small Molecule 64 Valve Replacement 64 Leukemia Cells 64 Therapeutic Agents 64 Bacteremia 64 Pathogenesis 64 Live Attenuated 64 Granted Orphan Drug 64 Colon Polyps 64 Carotid Stenting 64 Safinamide 64 Antiplatelet 64 Randomized Trials 64 Genetic Markers 64 Tyrosine Kinase Inhibitors 64 Slows Progression 64 Respiratory Syncytial Virus 64 Fixed Dose 64 Atypical Antipsychotics 64 Cytomegalovirus CMV 64 MKC# MT 64 Prognostic Significance 64 Lyophilized 64 Patent Covering 64 Nicotinic 64 Radiation Induced 64 Entry Inhibitor 64 Phenotypes 64 Immune Therapy 64 Invasive Breast Cancer 64 Radiation Dose 64 Galectins 64 Genetic Makeup 64 Veterinary Vaccines 64 Golimumab 64 Anti Angiogenic 64 Erosive 64 Cholesterol Lowering 64 Cholesterol Drugs 64 Thiovir 64 AnaSpec Introduces 64 Breast Ovarian Cancer 64 Improved Survival 64 Treat Heart Failure 64 AVI BioPharma Announces 64 Conjugates 64 Acne Treatments 64 Epilepsy Drugs 64 Hematologic Malignancies 64 Gene Expression Analysis 64 Demonstrates Sustained 64 Mesenchymal Stem Cells 64 Preclinical Efficacy 64 Antipsychotic Medications 64 Mutagenesis 64 Receptor Antagonists 64 PEG SN# 64 Pluripotent Stem Cells 64 Randomized Double blind 64 Helps Predict 64 Monocytes 64 Cell Transplant 64 Monoclonal 64 Recurrent Breast Cancer 64 Bosutinib 64 Neoplasms 64 Inhibits 64 Neck Cancers 64 Skin Lesions 64 Histone 64 Brain Plasticity 64 Detection Device 64 Cell Proliferation 64 Key Milestones 64 Solubility 64 Phase III Trial 64 Protein Protein Interaction 64 Antiviral Therapy 64 Protein Structures 64 Neutralizing Antibodies 64 Demonstrates Ability 64 Randomized Study 64 Nasal Powder 64 Genetic Variant 64 Guidelines Recommend 63 Invasive Fungal Infections 63 Trastuzumab DM1 63 Panzem 63 Chemoradiation 63 Alternative Treatments 63 HER2 Positive Breast Cancer 63 Cell Differentiation 63 Guidelines Issued 63 Human Neural Stem 63 Potentially Fatal 63 Colorectal Adenomas 63 Files Investigational 63 Toxicity Testing 63 Lung Cancers 63 Metastatic Prostate Cancer 63 Artery Disease 63 IL# PE#QQR 63 Cervical Cancer Vaccine 63 Antisense Oligonucleotides 63 recombinant subunit vaccine 63 Vaccine Prevents 63 Pulmonary Arterial Hypertension 63 Confirmatory Phase 63 Respiratory Distress 63 Cognitive Impairment 63 Complicated Skin 63 Anticancer Compound 63 Attenuates 63 Epithelium 63 Therapeutic Approaches 63 Blood Pressure Drugs 63 Randomized Phase 63 Macrolide 63 Patients Receiving 63 Oral Calcitonin 63 Retinal Disease 63 Initiates Phase II 63 MicroRNA 63 RNA Therapeutics 63 Virus Linked 63 Poster Presentations 63 Drug Combinations 63 Severe Asthma 63 Talabostat 63 Dose Response 63 Calcium Supplements 63 Electrophysiology Mapping 63 CNS Disorders 63 Shows Promise 63 Renal Function 63 Spinal Fusion 63 Transfection 63 Randomized Clinical Trial 63 Tumor Necrosis Factor 63 Anthrax Toxin 63 Cocaine Addiction 63 Brain Tumor Therapy 63 Integrase Inhibitor 63 Myocardial Ischemia 63 Hypertensive Patients 63 Anti Clotting Drug 63 Blood Stem Cells 63 Cethromycin 63 Demonstrates Positive 63 Knee Osteoarthritis 63 Gum Disease 63 Muscle Cells 63 Metastatic Renal Cell Carcinoma 63 Quantitation 63 Whole Genome Sequencing 63 Urinary Tract Infections 63 Receives Approvable Letter 63 Laryngeal Cancer 63 Biochip 63 Treatment Resistant 63 Systematic Review 63 Predict Risk 63 Earns Milestone Payment 63 Unmet Need 63 Dose Ranging 63 Circadian Clock 63 Study Showed 63 Liver Fibrosis 63 Genetic Mutations 63 Hepatitis B Virus 63 Prophylactic Treatment 63 Immunotherapeutics 63 Meta Analysis 63 Prodrug 63 Ischemic 63 Antimicrobial Coating 63 Prostate Cancer Cells 63 Genetically Engineered Animals 63 J Clin 63 Relapsing Multiple Sclerosis 63 Inhibitors 63 Help Predict 63 Molecular Mechanisms 63 Study Casts Doubt 63 Iron Overload 63 Subgroup Analysis 63 Uterine Cancer 63 Injectable Drug 63 Neoplasia 63 Expanded Indication 63 Progenitor Cell 63 Liver Tumors 63 Potent Antiviral Activity 63 Embryonic Stem Cells 63 Self Assembling 63 Bionanotechnology 63 Menopausal Symptoms 63 Could Detect 63 Inc Therapeutic Competitors 63 Pegylated 63 Pivotal Phase III 63 Eye Diseases 63 Cytometry 63 Muscle Wasting 63 Incretin 63 Maven Semantic 63 Fracture Risk 63 Hospital Acquired Pneumonia 63 Muscle Function 63 Newly Diagnosed 63 Regenerative Cells 63 Soft Tissue Sarcoma 63 Breast Density 63 Fewer Side Effects 63 Granulocyte Colony Stimulating Factor 63 Drug Resistant Tuberculosis 63 PET Scans 63 Patient Enrolment 63 Wound Dressings 63 Acne Drug 63 Breast Cancer Patients 63 Postmenopausal Osteoporosis 63 Diastolic Heart Failure 63 Infectious Disease Testing 63 Helicobacter Pylori 63 Gram Positive 63 Genes Associated 63 Proven Effective 63 Ozarelix 63 Inactivation 63 CCX# 63 Panzem R 63 Resubmission 63 Lung Cancer Vaccine 63 Antiviral Agents 63 Transplant Rejection 63 Successfully Treated 63 Hepatic Encephalopathy 63 Infected Patients 63 Bacterial Infections 63 Licenses Novel 63 Induced Pluripotent Stem Cells 63 Tumor Angiogenesis 63 Phase III Pivotal 63 Vaccine Trials 63 Abstract Accepted 63 Thromboembolic 63 Sexual Satisfaction 63 Adjunctive Therapy 63 Kinases 63 Pinpointed 63 biologic therapeutics 63 Breast Cancer Stem Cells 63 Breast Ultrasound 63 Viral Suppression 63 Bioresorbable 63 Significantly Improved 63 Catheter Associated 63 Proves Effective 63 Oncologic 63 Patient Outcomes 63 Neuroprotective Effects 63 Cyclooxygenase 2 63 Cerebrospinal Fluid 63 Ovarian Cancer Risk 63 Analogs 63 Study Shows Significant 63 Non Melanoma Skin 63 Healthbeat Report 63 Insulin Delivery 63 Localized Prostate Cancer 63 Modulates 63 ANN INTERN MED 63 Therapeutic Competitors Companies 63 Antithrombin 63 Antimalarial 63 Mol Med 63 Cytotoxic T 63 First Patient Treated 63 Theranostics 63 Pharmacodynamics 63 Oral Formulation 63 Being Studied 63 Advanced Prostate Cancer 63 Rigel R# 63 Reports Preclinical Data 63 Fulvestrant 63 Multicenter Trial 63 Organ Rejection 63 Spinal Fluid 63 Cholesterol Lowering Drugs 63 Radical Prostatectomy 63 Drug Eluting 63 Multiple Sclerosis Rheumatoid Arthritis 63 Childhood Immunizations 63 Hematopoietic Stem Cells 63 Autoimmune 63 Often Misdiagnosed 63 Synaptic Plasticity 63 Romidepsin 63 Bacterial Cell 63 cMET 63 Clinical Validation 63 Prostate Cancer Progression 63 Gets FDA Clearance 63 Presents Preclinical 63 Transplant Patients 63 Disease IBD 63 Study Reinforces 63 Novel Antibody 63 Oncolytic 63 Inflammatory Response 63 Efficacious 63 Chimigen TM 63 Nicotine Addiction 63 Oral Spray 63 CYT# potent vascular disrupting 63 Epitope 63 Stakeholder Insight 63 Surgical Procedures 62 Liver Injury 62 Noninvasive Prenatal 62 Anticoagulant 62 Fondaparinux